• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

9.330 -0.070 (-0.74%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,096,247
Open 9.380
Bid (Size) 9.230 (700)
Ask (Size) 9.380 (100)
Prev. Close 9.400
Today's Range 8.940 - 9.395
52wk Range 6.200 - 11.97
Shares Outstanding 74,484,166
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
1 Healthcare Stock with Impressive Fundamentals and 2 We Turn Down
July 02, 2026
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as... 
Via StockStory
News headline image
A Look Back at Therapeutics Stocks’ Q1 Earnings: Novavax (NASDAQ:NVAX) Vs The Rest Of The Pack
June 15, 2026
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including Novav... 
Via StockStory
Topics Artificial Intelligence

Performance

YTD
+30.9%
+30.9%
1 Month
+3.3%
+3.3%
3 Month
+15.0%
+15.0%
6 Month
+20.4%
+20.4%
1 Year
+36.4%
+36.4%

More News

Read More
News headline image
3 Cash-Burning Stocks We Think Twice About
June 04, 2026
Via StockStory
News headline image
Why Novavax (NVAX) Stock Is Trading Up Today
May 26, 2026
Via StockStory
Topics Artificial Intelligence Economy
News headline image
3 Reasons NVAX is Risky and 1 Stock to Buy Instead
May 25, 2026
Via StockStory
Topics Stocks
News headline image
3 Small-Cap Stocks That Fall Short
May 14, 2026
Via StockStory
Topics Energy
News headline image
3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally ↗
May 13, 2026
Via The Motley Fool
News headline image
GoodRx, RadNet, Addus HomeCare, Novavax, and Mettler-Toledo Shares Plummet, What You Need To Know
May 13, 2026
Via StockStory
Topics Economy
News headline image
The Top 5 Analyst Questions From Novavax’s Q1 Earnings Call
May 13, 2026
Via StockStory
Topics Earnings
News headline image
Biotech Stocks Rally on Hantavirus Fears: Is the Surge Overdone? ↗
May 11, 2026
Via The Motley Fool
Topics Death
News headline image
Why Novavax (NVAX) Stock Is Trading Up Today
May 08, 2026
Via StockStory
News headline image
Novavax (NVAX) Q3 2025 Earnings Transcript ↗
May 06, 2026
Via The Motley Fool
News headline image
Novavax (NVAX) Q1 2026 Earnings Transcript ↗
May 06, 2026
Via The Motley Fool
News headline image
Novavax (NVAX) Q2 2025 Earnings Transcript ↗
May 06, 2026
Via The Motley Fool
News headline image
Novavax (NASDAQ:NVAX) Surprises With Strong Q1 CY2026, Stock Soars
May 06, 2026
Via StockStory
News headline image
Novavax (NVAX) Q1 Earnings Report Preview: What To Look For
May 04, 2026
Via StockStory
News headline image
1 Cash-Heavy Stock to Target This Week and 2 We Ignore
April 24, 2026
Via StockStory
News headline image
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
April 23, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Spotting Winners: AbbVie (NYSE:ABBV) And Therapeutics Stocks In Q4
April 22, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Therapeutics Q4 Earnings: Novavax (NASDAQ:NVAX) Simply the Best
April 20, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
April 20, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Q4 Earnings Highs And Lows: Gilead Sciences (NASDAQ:GILD) Vs The Rest Of The Therapeutics Stocks
April 12, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Novavax (NVAX): Buy, Sell, or Hold Post Q4 Earnings?
April 09, 2026
Via StockStory
News headline image
3 Reasons NVAX is Risky and 1 Stock to Buy Instead
April 08, 2026
Via StockStory
Topics Stocks
News headline image
1 Russell 2000 Stock with Exciting Potential and 2 We Avoid
April 07, 2026
Via StockStory

Frequently Asked Questions

Is Novavax, Inc. - Common Stock publicly traded?
Yes, Novavax, Inc. - Common Stock is publicly traded.
What exchange does Novavax, Inc. - Common Stock trade on?
Novavax, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Novavax, Inc. - Common Stock?
The ticker symbol for Novavax, Inc. - Common Stock is NVAX on the Nasdaq Stock Market
What is the current price of Novavax, Inc. - Common Stock?
The current price of Novavax, Inc. - Common Stock is 9.330
When was Novavax, Inc. - Common Stock last traded?
The last trade of Novavax, Inc. - Common Stock was at 07/10/26 04:00 PM ET
What is the market capitalization of Novavax, Inc. - Common Stock?
The market capitalization of Novavax, Inc. - Common Stock is 694.94M
How many shares of Novavax, Inc. - Common Stock are outstanding?
Novavax, Inc. - Common Stock has 695M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap